Pfizer says three drugs in Phase III trials for deadly cancers

06/5/2007 | Forbes

Pfizer says three of its cancer drugs are set to undergo large-scale Phase III trials for several deadly cancers, one of them for an extended indication. The firm said its Sutent for stomach and kidney cancers is being tested for liver cancer, its Axitinib for pancreatic cancer, and its CP-751,871 compound for non-small-cell lung cancer.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD